Correlation Between Bone Biologics and Demant AS

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bone Biologics and Demant AS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bone Biologics and Demant AS into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bone Biologics Corp and Demant AS ADR, you can compare the effects of market volatilities on Bone Biologics and Demant AS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bone Biologics with a short position of Demant AS. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bone Biologics and Demant AS.

Diversification Opportunities for Bone Biologics and Demant AS

0.77
  Correlation Coefficient

Poor diversification

The 3 months correlation between Bone and Demant is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Bone Biologics Corp and Demant AS ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Demant AS ADR and Bone Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bone Biologics Corp are associated (or correlated) with Demant AS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Demant AS ADR has no effect on the direction of Bone Biologics i.e., Bone Biologics and Demant AS go up and down completely randomly.

Pair Corralation between Bone Biologics and Demant AS

Assuming the 90 days horizon Bone Biologics Corp is expected to generate 25.66 times more return on investment than Demant AS. However, Bone Biologics is 25.66 times more volatile than Demant AS ADR. It trades about 0.1 of its potential returns per unit of risk. Demant AS ADR is currently generating about 0.04 per unit of risk. If you would invest  2.00  in Bone Biologics Corp on August 30, 2024 and sell it today you would earn a total of  2,778  from holding Bone Biologics Corp or generate 138900.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Bone Biologics Corp  vs.  Demant AS ADR

 Performance 
       Timeline  
Bone Biologics Corp 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Bone Biologics Corp are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile technical and fundamental indicators, Bone Biologics showed solid returns over the last few months and may actually be approaching a breakup point.
Demant AS ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Demant AS ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Bone Biologics and Demant AS Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bone Biologics and Demant AS

The main advantage of trading using opposite Bone Biologics and Demant AS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bone Biologics position performs unexpectedly, Demant AS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Demant AS will offset losses from the drop in Demant AS's long position.
The idea behind Bone Biologics Corp and Demant AS ADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments